-
公开(公告)号：US20190151440A1
公开(公告)日：2019-05-23
申请号：US16023871
申请日：2018-06-29
IPC分类号： A61K39/21 , A61K39/12 , C07K14/005
摘要： Disclosed herein are mosaic conserved region HIV polypeptides and immunogenic polypeptides including one or more of the mosaic conserved region polypeptides. In some embodiments, the immunogenic polypeptides are included in an immunogenic composition, such as a polyvalent immunogenic composition. Also disclosed herein are methods for treating or inhibiting HIV in a subject including administering one or more of the disclosed immunogenic polypeptides or compositions to a subject having or at risk of HIV infection. In some embodiments, the methods include inducing an immune response in a subject comprising administering to the subject at least one of the disclosed immunogenic polypeptides or a nucleic acid encoding at least one of the immunogenic polypeptides.
-
公开(公告)号：US11235055B2
公开(公告)日：2022-02-01
申请号：US16023871
申请日：2018-06-29
IPC分类号： A61K39/21 , A61K39/12 , C07K14/16 , C07K14/005
摘要： Disclosed herein are mosaic conserved region HIV polypeptides and immunogenic polypeptides including one or more of the mosaic conserved region polypeptides. In some embodiments, the immunogenic polypeptides are included in an immunogenic composition, such as a polyvalent immunogenic composition. Also disclosed herein are methods for treating or inhibiting HIV in a subject including administering one or more of the disclosed immunogenic polypeptides or compositions to a subject having or at risk of HIV infection. In some embodiments, the methods include inducing an immune response in a subject comprising administering to the subject at least one of the disclosed immunogenic polypeptides or a nucleic acid encoding at least one of the immunogenic polypeptides.
-
公开(公告)号：US20160213772A1
公开(公告)日：2016-07-28
申请号：US15025733
申请日：2014-09-30
发明人： Bette T.M. Korber , Tomas Hanke , Andrew McMichael
IPC分类号： A61K39/21 , C07K14/005
CPC分类号： A61K39/21 , A61K39/12 , C07K14/005 , C12N2740/16034
摘要： Disclosed herein are mosaic conserved region HIV polypeptides and immunogenic polypeptides including one or more of the mosaic conserved region polypeptides. In some embodiments, the immunogenic polypeptides are included in an immunogenic composition, such as a polyvalent immunogenic composition. Also disclosed herein are methods for treating or inhibiting HIV in a subject including administering one or more of the disclosed immunogenic polypeptides or compositions to a subject having or at risk of HIV infection. In some embodiments, the methods include inducing an immune response in a subject comprising administering to the subject at least one of the disclosed immunogenic polypeptides or a nucleic acid encoding at least one of the immunogenic polypeptides.
摘要翻译： 本文公开了马赛克保守区HIV多肽和包括一个或多个马赛克保守区多肽的免疫原性多肽。 在一些实施方案中，免疫原性多肽包括在免疫原性组合物中，例如多价免疫原性组合物。 本文还公开了用于治疗或抑制受试者中的HIV的方法，包括将一种或多种所公开的免疫原性多肽或组合物施用于具有或有HIV感染危险的受试者。 在一些实施方案中，所述方法包括在受试者中诱导免疫应答，包括向受试者施用至少一种所公开的免疫原性多肽或编码至少一种免疫原性多肽的核酸。
-
公开(公告)号：US10010606B2
公开(公告)日：2018-07-03
申请号：US15025733
申请日：2014-09-30
IPC分类号： A61K39/21 , A61K39/12 , C07K14/005
CPC分类号： A61K39/21 , A61K39/12 , C07K14/005 , C12N2740/16034
摘要： Disclosed herein are mosaic conserved region HIV polypeptides and immunogenic polypeptides including one or more of the mosaic conserved region polypeptides. In some embodiments, the immunogenic polypeptides are included in an immunogenic composition, such as a polyvalent immunogenic composition. Also disclosed herein are methods for treating or inhibiting HIV in a subject including administering one or more of the disclosed immunogenic polypeptides or compositions to a subject having or at risk of HIV infection. In some embodiments, the methods include inducing an immune response in a subject comprising administering to the subject at least one of the disclosed immunogenic polypeptides or a nucleic acid encoding at least one of the immunogenic polypeptides.
-
-
-
搜索结果
4 条记录 (耗时 0.032 秒)
